Search clinical trials for: 68Ga-BNOTA-PRGD2

Total 637 results

Vanderbilt-Ingram Cancer Center

Completed

68Ga-DOTATATE PET Scan in Neuroendocrine Cancer (68Ga)

Neuroendocrine Carcinoma

United States
Peking University

Not yet recruiting

Evaluation of HER2-targeted Therapy for Gastric Cancer and Establishment and Verification of Monitoring System

HER2 Positive Gastric Cancer

China
Ochsner Health System

Unknown

68Ga-DOTATATE PET Scan Imaging in Patients With Neuroendocrine Tumors

Neuroendocrine Tumor | Neuroendocrine Carcinoma | Carcinoid Tumor | Neuroendocrine Cancer | Carcinoid | Islet Cell Tumor | Neuroendocrine | Apudoma

United States
The First Affiliated Hospital of Xiamen University

Recruiting

Characterizing Spondyloarthritis With 68Ga-FAPI PET/CT

Ankylosing Spondylitis | Spondyloarthritis | Axial Spondyloarthritis

China
Peking Union Medical College Hospital

Recruiting

68Ga-P16-093 and 68Ga-PSMA-11 PET/CT Imaging in the Same Group of Primary Prostate Cancer Patients

Prostate Cancer

China
Peking Union Medical College Hospital

Recruiting

68Ga-NOTA-RM26 PET/CT in Glioma Patients

Glioma

China
Chang Gung Memorial Hospital

Recruiting

Comparison of 68Ga-FAPI-46 PET and 18F-FDG PET in Lung Cancer

Lung Cancer

Taiwan
Peking Union Medical College Hospital

Recruiting

68Ga-P15-041 and 68Ga-PSMA-11 PET/CT Imaging in the Same Group of Prostate Bone Metastasis

Prostate Cancer Metastatic

China
Shanghai General Hospital, Shanghai Jiao Tong University...
NanoMab Technology (UK) Limited

Completed

68Ga-THP-PSMA PET/CT in Prostate Cancer: Clinical Stage and Restage

Prostate Cancer

China
Radionetics Oncology

Recruiting

Phase 1 Study of 68Ga-R8760

Adrenocortical Carcinoma

United States
Centre de recherche du Centre hospitalier universitaire...

Recruiting

68Ga-DOTATATE Neuroblastoma Imaging Pilot

Neuroblastoma

Canada
Peking University First Hospital

Recruiting

68Ga-N188 PET/CT Imaging in Malignancy

Neoplasms

China
Anhui Provincial Hospital

Recruiting

Head-to-head Comparison of [68Ga]Ga-PSMA-D5 With [68Ga]Ga-PSMA-11 PET/CT in PCa Diagnosis, Recurrence, and Metastasis

Prostate Cancer | PET/CT

China
Peking Union Medical College Hospital

Recruiting

68Ga-P16-093 and 68Ga-PSMA-617 PET/CT Imaging in the Same Group of Prostate Cancer Patients

Prostate Cancer

China
Peking Union Medical College Hospital

Recruiting

68Ga-PMD22 PET/CT Examination Targeting CLDN18.2

Gastrointestinal Cancer

China
Jonsson Comprehensive Cancer Center

No longer available

68Ga DOTATATE PET/CT in Neuroendocrine Tumors (Expanded Access)

Neuroendocrine Tumors | Medullary Thyroid Cancer | Carcinoid Cancer | Cancers Expressing Somatostatin Receptors

United States
Peking Union Medical College Hospital

Recruiting

68Ga-NY104 PET/CT in Patients With Metastatic Clear Cell Renal Cell Carcinoma

Metastatic Clear Cell Renal Cell Carcinoma

China
Peking Union Medical College Hospital

Unknown

Application of 68Ga-DOTA-TATE and 68Ga-DOTA-JR11 PET/CT in the Diagnosis and Evaluation of TIO

Tumor-Induced Osteomalacia

China
Wuhan Union Hospital, China

Recruiting

68Ga-HX01 PET in Healthy Volunteers and Malignant Tumors Patients

Malignant Neoplasm

China
Peking Union Medical College Hospital

Recruiting

68Ga-FAPI-FS PET/CT and PET/MR in Pancreatic Cancer

Pancreatic Cancer

China
Jagiellonian University
University Hospital in Krakow

Recruiting

Clinical Application of the J-PET Scanner Prototype (JPET2Clinic)

Prostatic Neoplasms | Prostatic Hyperplasia | Prostate Cancer | Neuroendocrine Tumors | Neuroendocrine Carcinoma | Prostate Cancer Metastatic

Poland
RenJi Hospital

Recruiting

Clinical Application of 68Ga-FAPI PET Imaging in Detection of Ovarian Cancer Recurrence

Ovarian Cancer | Epithelial Ovarian Cancer | Positron Emission Tomography | 68Ga-FAPI

China
Affiliated Hospital of Jiangnan University

Recruiting

68Ga-labeled NY105 PET Imaging in Patients

Cancer

China
First Affiliated Hospital of Fujian Medical University

Recruiting

Value of Chemokine Receptor CXCR4 Imaging for Diagnosis and Prognostic Evaluation in Lymphoproliferative Diseases

Lymphoma | Leukemia | Multiple Myeloma

China
Ipsen

Completed

To Evaluate the Optimal Dose of 68Ga-OPS202 as a PET (Positron Emission Tomography) Imaging Agent in Subjects With Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET)

Gastro-Enteropancreatic Neuroendocrine Tumor

United States, Austria, Denmark
First Affiliated Hospital of Chongqing Medical...

Recruiting

68Ga-PSFA PET Imaging in Patients With PSMA/FAP Positive Disease

Positron-Emission Tomography | FAP | PSMA

China
Affiliated Hospital of Jiangnan University

Recruiting

68Ga-labeled NY104 PET Imaging in Patients

Renal Cell Carcinoma

China
British Columbia Cancer Agency

Not yet recruiting

Dynamic Whole Body PET/ MRI

Prostatic Cancer

Canada
Massachusetts General Hospital
National Cancer Institute (NCI)

Recruiting

Evaluation of PET Probe [68Ga]CBP8 in the Detection of Radiation Induced Tissue Injury

Lung Cancer | Pancreas Cancer | Radiation Fibrosis | Radiation Induced Lung Injury

United States
Peking Union Medical College Hospital

Unknown

68Ga-DOTATATE PET/CT in Neuroendocrine Tumor

Neuroendocrine Tumors

China
Peking Union Medical College Hospital

Recruiting

Application of 68Ga-labeled ACE2 Targeting Probe PET/CT Imaging in Tracing ACE2 Expression and Diagnosis of Lung Cancer

Lung Cancer | Healthy Human

China
Memorial Sloan Kettering Cancer Center
Pentixapharm AG

Recruiting

In-Human CXCR4 Imaging of Blood Cancers Using [68Ga]-Pentixafor-PET

Multiple Myeloma | Non-Hodgkin Lymphoma | Erdheim-Chester Disease | Rosai-Dorfman Disease | Histiocytic Neoplasms

United States
Novartis Pharmaceuticals

Recruiting

Study of [68Ga]-FF58 in Patients With Selected Solid Tumors Expected to Overexpress αvβ3 and αvβ5 Integrins.

Brain Neoplasms | Glioblastoma Multiforme | Gastroesophageal Adenocarcinoma | Pancreatic Ductal Adenocarcinoma

Germany, United States, France
Peking Union Medical College Hospital

Unknown

Chemokine Receptor CXCR4-targeting Molecular Imaging for Metabolic Characterization of Multiple Myeloma and Lymphoma

Lymphoma | Multiple Myeloma

China
Lightpoint Medical Limited

Not yet recruiting

The LightPath® and 68Ga-RM2 in Breast Cancer Study

Breast Cancer

United Kingdom
Nantes University Hospital

Withdrawn

Relevance Evaluation of [68Ga]Ga-PentixaFor for Initial Staging and Detection of Minimal Residual Disease in Multiple Myeloma Patients. (PENTI-MIDAS)

Multiple Myeloma

France
Peking University First Hospital

Recruiting

68Ga-P3 PET/CT Imaging in Malignancy

Neoplasms

China
Nantes University Hospital

Recruiting

Relevance of [68Ga]Ga -PentixaFor-PET for Initial Staging and Therapeutic Evaluation of Multiple Myeloma in First Line Treatment (PentiMyelo)

Multiple Myeloma

France
German Cancer Research Center
University Hospital Freiburg; ABX CRO; Friedrich-Alexander-Universität Erlangen-Nürnberg

Completed

Ga-68-PSMA-11 in High-risk Prostate Cancer

Prostate Cancer | Prostate Cancer Metastatic | High-risk Prostate Cancer | Lymphnode Metastasis

Austria, Germany
Jewish General Hospital

Completed

SUV on 68Ga-DOTATATE PET/CT and Ki-67 Index in Neuro-Endocrine Tumors

Neuroendocrine Tumors

Canada
The First Affiliated Hospital of Soochow University

Not yet recruiting

PET / CT Imaging and Safety in Patients With Lymphoma Treated With CD19 Car-t Cells

Lymphoma
Peking Union Medical College Hospital

Recruiting

68Ga-FAPI-04 PET/CT for the Detection of Oral Carcinoma

Oral Carcinoma

China
First Affiliated Hospital of Fujian Medical University

Recruiting

68Ga-FAPI-JH04 PET/CT: Dosimetry and Biodistribution Studies

Malignant Neoplasm

China
Peking University Cancer Hospital & Institute

Recruiting

PD-L1 Targeting Nanobody Probe for PET Imaging of Solid Tumor

Melanoma | Lung Cancer | PD-L1 | PET/CT

China
Five Eleven Pharma, Inc.

Completed

Preliminary Evaluation of Uptake in Bone Metastases and Biodistribution of [68Ga]P15-041

Prostate Cancer | Bone Metastases

United States
Biomedical Radiation Sciences
Swedish Cancer Society; Affibody

Completed

PET Study of Breast Cancer Patients Using [68Ga]ABY-025

Breast Cancer

Sweden
Peking Union Medical College Hospital

Not yet recruiting

Application of 68GA-labeled CD73 Targeting Probe PET/CT Imaging in the Diagnosis of Breast Cancer

Breast Cancer

China
Peking Union Medical College Hospital

Not yet recruiting

68Ga-P16-093 PET/CT Imaging in the Salivary Gland

Primary Sjögren Syndrome
Peking Union Medical College Hospital

Recruiting

68Ga-P16-093 PET/CT Imaging in Glioma Patients

Glioma

China
First Affiliated Hospital of Fujian Medical University

Recruiting

68Ga-FAPI PET/CT in Patients With Various Fibrotic Disease

Fibrosis | Positron-Emission Tomography

China

Search clinical trials for: 68Ga-BNOTA-PRGD2

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Brazil

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations